Extrovis and Dr. Reddy’s (RDY) Laboratories announced the launch of Fluorouracil Cream, 0.5%, an authorized generic and therapeutic equivalent of C ...

On August 13, 2025, Dr. Reddy’s Laboratories announced its participation in an upcoming investor conference organized by Centrum Broking, scheduled for August 21, 2025.